Omada Health (NASDAQ:OMDA) Given New $19.00 Price Target at Wells Fargo & Company

Posted by Stanley Muller on Nov 7th, 2026

Omada Health (NASDAQ:OMDA – Free Report) had its target price cut by Wells Fargo & Company from $22.00 to $19.00 in a report issued on Friday,Benzinga reports. They currently have an equal weight rating on the stock.

Several other research firms also recently weighed in on OMDA. Zacks Research downgraded shares of Omada Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday. Citigroup reaffirmed an “outperform” rating on shares of Omada Health in a research note on Friday, August 14th. BMO Capital Markets reiterated an “outperform” rating and issued a $24.00 price objective on shares of Omada Health in a report on Friday, August 7th. Robert W. Baird raised their target price on shares of Omada Health from $15.00 to $25.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 12th. Finally, BTIG Research restated a “buy” rating and set a $35.00 target price on shares of Omada Health in a report on Friday, September 11th. Eleven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Omada Health has a consensus rating of “Moderate Buy” and a consensus price target of $26.33.

Read Our Latest Analysis on Omada Health

Omada Health Trading Down 20.4%

OMDA stock traded down $3.86 during midday trading on Friday, reaching $15.09. The stock had a trading volume of 4,709,304 shares, compared to its average volume of 1,032,454. The company’s fifty day simple moving average is $20.14 and its 200 day simple moving average is $17.74. The company has a market cap of $923.81 million, a price-to-earnings ratio of 71.86 and a beta of 2.13. Omada Health has a 52-week low of $10.28 and a 52-week high of $25.45.

Omada Health (NASDAQ:OMDA – Get Free Report) last announced its earnings results on Thursday, November 5th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.08. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The company had revenue of $91.31 million for the quarter. Sell-side analysts predict that Omada Health will post 0.09 EPS for the current year.

Insider Buying and Selling

In other news, CEO Sean Duffy sold 12,944 shares of Omada Health stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $19.22, for a total transaction of $248,783.68. Following the transaction, the chief executive officer owned 382,594 shares in the company, valued at $7,353,456.68. The trade was a 3.27% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Steven Cook sold 6,800 shares of the business’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $21.86, for a total transaction of $148,648.00. Following the transaction, the chief financial officer directly owned 173,906 shares in the company, valued at approximately $3,801,585.16. The trade was a 3.76% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 119,014 shares of company stock valued at $2,711,405 over the last 90 days. Insiders own 6.38% of the company’s stock.

Hedge Funds Weigh In On Omada Health

Several institutional investors and hedge funds have recently bought and sold shares of OMDA. BlackRock Inc. purchased a new stake in shares of Omada Health in the 2nd quarter valued at approximately $48,775,000. Jefferies Financial Group Inc. acquired a new stake in shares of Omada Health during the 2nd quarter worth approximately $15,016,000. Madryn Asset Management LP purchased a new stake in shares of Omada Health during the 2nd quarter valued at approximately $12,814,410. Walleye Capital LLC purchased a new stake in shares of Omada Health during the 2nd quarter valued at approximately $11,648,000. Finally, Bank of America Corp DE acquired a new position in Omada Health in the second quarter valued at approximately $6,880,000.

Key Omada Health News

Here are the key news stories impacting Omada Health this week:

Positive Sentiment: Omada reported Q3 revenue of $91 million, up 34% year over year, and total members grew 36% to a record 1.1 million. Net income was $7 million versus a year-ago loss, while adjusted EBITDA increased to $12 million. The company also raised its full-year 2026 financial outlook. Omada Health Reports Third Quarter 2026 Results
Positive Sentiment: Quarterly revenue exceeded FactSet’s estimate, and reported earnings also topped consensus estimates, providing evidence of stronger-than-expected operating performance. Earnings Flash: Q3 Revenue
Neutral Sentiment: Unusual options activity was reported after Omada’s earnings, signaling heightened trading interest but not indicating a clear direction for the stock. Unusual Options Volume Report
Negative Sentiment: Several analysts took a more cautious stance: Wells Fargo cut its price target to $19 and maintained an “equal weight” rating, while Zacks Research downgraded OMDA from “strong buy” to “hold.” Wells Fargo analyst actions Zacks Research analyst action
Negative Sentiment: Barclays also lowered its target from $24 to $22, although it retained an “overweight” rating. Barclays analyst action

Omada Health Company Profile

(Get Free Report)

Omada Health, Inc (NASDAQ: OMDA) is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines personalized health coaching, clinical support, behavioral-change tools and connected devices to help members monitor and improve their health.

The company’s offerings focus primarily on cardiometabolic conditions, including diabetes, prediabetes, hypertension and obesity, as well as musculoskeletal conditions. Depending on the program, members may receive access to digital lessons, health tracking, remote monitoring, care teams and clinical guidance through Omada’s technology platform.

Omada Health was founded in 2011 and serves employers, health plans and other healthcare organizations in the United States.